 |
인쇄하기
취소
|
KORUS FTA sets new milestone for domestic drug makers
Published: 2007-06-14 06:58:00
Updated: 2007-06-14 06:58:00
Following the FTA ratification, Korea's pharmaceutical industry needs to enhance productivity and efficiency through restructuring.
But there are some bright spots. Korean companies now can bet on the possibility of mutual recognition arrangement (MRA) on generic drugs.
The conclusion of the FTA has laid the foundation for Korean pharmaceutical companies to be able to comply with intern...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.